Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Return on Sales (2016 - 2025)

Historic Return on Sales for Ani Pharmaceuticals (ANIP) over the last 16 years, with Q3 2025 value amounting to 0.12%.

  • Ani Pharmaceuticals' Return on Sales rose 2800.0% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 600.0%. This contributed to the annual value of 0.03% for FY2024, which is 700.0% down from last year.
  • According to the latest figures from Q3 2025, Ani Pharmaceuticals' Return on Sales is 0.12%, which was up 2800.0% from 0.04% recorded in Q2 2025.
  • In the past 5 years, Ani Pharmaceuticals' Return on Sales registered a high of 0.13% during Q1 2024, and its lowest value of 0.4% during Q4 2021.
  • Over the past 5 years, Ani Pharmaceuticals' median Return on Sales value was 0.02% (recorded in 2024), while the average stood at 0.06%.
  • In the last 5 years, Ani Pharmaceuticals' Return on Sales crashed by -3300bps in 2021 and then skyrocketed by 3500bps in 2022.
  • Over the past 5 years, Ani Pharmaceuticals' Return on Sales (Quarter) stood at 0.4% in 2021, then skyrocketed by 89bps to 0.05% in 2022, then skyrocketed by 119bps to 0.01% in 2023, then plummeted by -715bps to 0.05% in 2024, then skyrocketed by 317bps to 0.12% in 2025.
  • Its last three reported values are 0.12% in Q3 2025, 0.04% for Q2 2025, and 0.08% during Q1 2025.